MARKET

CRON

CRON

Cronos Group
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.05
-0.26
-4.90%
After Hours: 5.02 -0.03 -0.59% 16:13 09/23 EDT
OPEN
5.27
PREV CLOSE
5.31
HIGH
5.27
LOW
5.00
VOLUME
4.03M
TURNOVER
--
52 WEEK HIGH
10.56
52 WEEK LOW
4.000
MARKET CAP
1.77B
P/E (TTM)
10.13
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Aurora Cannabis down 10% on soft revenue outlook
It's the first earnings report for Aurora (ACB) since Miguel Martin was named as the new CEO on September 8. For 2020 FQ4, the company lost $1.9B; for all of
Seekingalpha · 22h ago
Marijuana Stocks: Aurora Cannabis Earnings Due As New CEO Steps In
Investor's Business Daily · 1d ago
Marijuana Stocks: Aurora Cannabis Earnings Due As New CEO Steps In
Investor's Business Daily · 1d ago
MJ: Yes, The Marijuana ETF Has Provided A Steady 6-7% Yield
With the Fed aiming to keep rates near zero for at least the next few years, income seekers will need to venture out on the risk spectrum for higher yields.One pretty unconventional sector that could help fill the income gap is marijuana.The fund's largest underlying components don't pay a dividend, but securities lending allows MJ to pay a 6%+ yield.I'll examine MJ one more time to review the income generation process and discuss its place within an income portfolio.
Seekingalpha · 2d ago
Cronos Group Recognized by the Toronto Stock Exchanges TSX30 Program
TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that on September 15, 2020, the Company was recognized by the Toronto Stock Exchange as the third top-performing company on the Toronto Stock Exchange’s 2020 TSX30
GlobeNewswire · 09/15 15:00
Cronos Group Inc. to Present at the CIBC 19th Annual Eastern Institutional Investor Conference
TORONTO, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at the CIBC 19th Annual Eastern Institutional Investor Conference
GlobeNewswire · 09/14 20:30
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
Welcome to the Cannabis Countdown. In This Week's Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of September 7th - 13th, 2020.Without further ado, let's get started.* Yahoo Finance readers, please click here to view full article.10\.
Benzinga · 09/14 14:20
What Kind Of Investors Own Most Of Cronos Group Inc. (TSE:CRON)?
Every investor in Cronos Group Inc. (TSE:CRON) should be aware of the most powerful shareholder groups. Generally...
Simply Wall St. · 09/11 18:08
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CRON. Analyze the recent business situations of Cronos Group through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CRON stock price target is 7.31 with a high estimate of 10.64 and a low estimate of 4.300.
EPS
Institutional Holdings
Institutions: 353
Institutional Holdings: 46.39M
% Owned: 13.26%
Shares Outstanding: 349.89M
TypeInstitutionsShares
Increased
51
3.05M
New
71
-915.56K
Decreased
66
7.11M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.55%
Pharmaceuticals & Medical Research
-1.30%
Key Executives
Chairman/President/Chief Executive Officer/Director
Michael Gorenstein
Chief Financial Officer
Jerry Barbato
Corporate Executive
Robert Rosenheck
Executive Vice President
Xiuming Shum
Senior Vice President
Anna Shlimak
General Manager
Jeffrey Jacobson
Other
Todd Abraham
Lead Director/Independent Director
James Rudyk
Director
Jody Begley
Director
Murray Garnick
Director
Heather Newman
Independent Director
Jason Adler
Independent Director
Bronwen Evans
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CRON
Cronos Group Inc is a cannabinoid company. The Company is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivations Ltd, Cronos Israel G.S. Manufacturing Ltd, Cronos Israel G.S. Store Ltd and Cronos Israel G.S. Pharmacies Ltd.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Cronos Group Inc stock information, including NASDAQ:CRON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRON stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CRON stock methods without spending real money on the virtual paper trading platform.